👏💪 It’s out! Our latest study addresses a critical need in gastroenterology: early and accurate identification of Barrett’s Esophagus (BE) patients at risk of progression to esophageal adenocarcinoma (EAC).
We developed two support vector machine models to pave the way for more precise surveillance strategies and earlier interventions in BE.
đź‘€ Check out full article
Related Posts
We’re excited to announce that HepatoPredict, our CE-IVD prognostic tool to assess hepatocellular carcinoma (HCC) recurrence in the context of
HepatoDetect Shows Strong Potential for Early HCC Detection HepatoDetect, our AI-driven liquid biopsy platform designed for the early detection of
Now partnering with global institutions and investors to scale innovation where it matters most. Ophiomics is building the world’s first
Fatty liver disease is a metabolic dysfunction that affects approximately one in every four adults and is particularly common among
+351 211 369 829 